Virax Biolabs Group Limited financial statements, including revenue, expenses, profit, and loss

The total revenue of VRAX for the last semiannual is 79.92 k USD, and it's 4.47% higher compared to the previous semiannual. The net income of H2 23 is -3.82 M USD.